Bridge Therapeutics, Inc. — Form D/A

Bridge Therapeutics, Inc. of BIRMINGHAM, AL, a company, filed a Form D amendment with the SEC on 2018-02-23. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (26)

Showing 25 of 26 people.

NameRoleLocation
Joseph S MullinExecutive OfficerBirmingham, AL
Joseph MullinRelated PersonBirmingham, AL
Russell KelleyRelated PersonBirmingham, AL
Christopher Patrick PalutisDirectorRichmond, KY
Joseph Patrick MullinDirectorNew York, NY
Elizabeth Gregory KelleyDirectorLucedale, MS
Jason Patrick BaileyDirectorKeller, TX
Timothy Grant PearaExecutive OfficerAsheville, NC
James Gregory SullivanDirectorBirmingham, AL
James Gregory SullivanExecutive OfficerBirmingham, AL
Joseph S MullinDirectorBirmingham, AL
David H BergstromDirectorBirmingham, AL
David H BergstromRelated PersonBirmingham, AL
Elizabeth G KelleyDirectorBirmingham, AL
Tim G PearaExecutive OfficerBirmingham, AL
James G SullivanDirectorBirmingham, AL
James G SullivanExecutive OfficerBirmingham, AL
James G SullivanRelated PersonBirmingham, AL
Russell G KelleyPromoterBirmingham, AL
Diana H HarshbargerDirectorBirmingham, AL
Kelley S AltonDirectorBirmingham, AL
Kelley S AltonExecutive OfficerBirmingham, AL
Kelley S AltonRelated PersonBirmingham, AL
Diana HarshbargerRelated PersonBirmingham, AL
Elizabeth KelleyRelated PersonBirmingham, AL

Other filings by this issuer (4)

FiledFormOfferingSold
2023-12-18D$1.5M$321K
2019-04-24D/A—$2.0M
2019-03-08D/A——
2018-02-22D——

More